Obinutuzumab/Lenalidomide Combo Safe, Effective in Advanced Follicular Lymphoma

The combination of obinutuzumab and lenalidomide was found to be effective in relapsed or refractory follicular B-cell lymphoma.

Source: CancerNetwork - August 9, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news